| Yazarlar (4) |
Prof. Dr. Kemal ÖRNEK
Kirikkale Üniversitesi, Türkiye |
Z. Onaran
Kirikkale Üniversitesi, Türkiye |
|
A. Ergin
Kirikkale Üniversitesi, Türkiye |
|
N. F. Yalçndag
Ankara Üniversitesi, Türkiye |
| Özet |
| I thank the authors for their interesting case series describing the use of ketamine sedation for the treatment of retinopathy of prematurity. 1 I agree that no ideal agent exists but have reservations about the use of ketamine in this age group, which merits discussion. There still remain questions over the potential neurotoxic effects of some anaesthetic agents in this age group, and ketamine has been the most strongly implicated in the debate. 2 Volatile agents, midazolam, and ketamine can cause neuroapoptosis (programmed neuronal cell death) in the neonatal rat model, evidence which has concerned the Food and Drug Administration in the United States to instigate trials in a primate model. 2 Exposure may result in adverse cognitive sequelae, but at present, the risk is difficult to quantify. 2 Remifentanil has been shown to have predictable pharmacokinetics and pharmacodynamics in neonates, importantly an … |
| Anahtar Kelimeler |
| Makale Türü |
Özgün Makale
|
| Makale Alt Türü | SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale |
| Dergi Adı | Eye |
| Dergi ISSN | 0950-222X Wos Dergi Scopus Dergi |
| Dergi Tarandığı Indeksler | SCI |
| Makale Dili | İngilizce |
| Basım Tarihi | 11-2008 |
| Cilt No | 22 |
| Sayı | 11 |
| Sayfalar | 1450 / 1451 |
| DOI Numarası | 10.1038/eye.2008.56 |
| Atıf Sayıları | |
| WoS | 2 |
| SCOPUS | 2 |
| Google Scholar | 3 |
